Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01417260 · ClinicalTrials.gov registry record
Effects of Breast Feeding on Post-Cesarean and Post-Vaginal Delivery Pain
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 130
- Enrollment target
NCT01417260: Completed study, sponsored by Stanford University.
NCT01417260 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01417260 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
Oxytocin is a hormone that is released in response to distension of the cervix and uterus during labor, and after breast feeding as a result of nipple stimulation. In addition to oxytocin facilitating birth and breastfeeding, oxytocin has a number of effects on maternal behavior including bonding, social recognition, anxiolysis, sexual arousal. The role of oxytocin in pain modulation has recently been highlighted. Intranasal or intrathecal (spinal) administration has been found to impact pain modulation. The administration of intravenous oxytocin has not provided effective analgesia because oxytocin is unable to pass to your brain. The role of breastfeeding on analgesia is poorly investigated, which is why we are carrying out this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01417260
The ClinicalTrials.gov registry entry for NCT01417260 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01417260 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01417260 about?
NCT01417260 is a clinical study titled "Effects of Breast Feeding on Post-Cesarean and Post-Vaginal Delivery Pain". Oxytocin is a hormone that is released in response to distension of the cervix and uterus during labor, and after breast feeding as a result of nipple stimulation. In addition to oxytocin facilitating birth and breastfeeding, oxytocin has a number of effects on maternal behavior including bonding, s...
What is the current status of trial NCT01417260?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2011-08. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01417260?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.